HomeNDC LookupIngredientsBisacodyl › 49483-0003-10
image loading
(from DailyMed)

STIMULANT LAXATIVE BISACODYL 5 mg Tablet, Delayed Release, 1,000-count

by TIME CAP LABORATORIES, INC. · 1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (49483-003-10)
NDC 49483-0003-10
🏷️ FDA NDC (as labeled) 49483-003-10 billing pads the product segment with a zero
This package
Contains1,000-count Cost per ea$0.0464 NADAC Per package$46.40 / 1000 tablets Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.2307/unit — full pricing hub ↓
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 49483-003-10
Product NDC 49483-003
11-digit billing NDC 49483000310
NCPDP billing unit EA — each (per item)
RxCUI 308753
UNII 10X0709Y6I
UPC 0349483003529
Application # part334
SPL Set ID e0a9f8d9-660b-431c-8043-6d8ec81f98e5
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH NOT FINAL
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-04-01
Route ORAL
Dosage form TABLET, DELAYED RELEASE
Substance BISACODYL
GPI-14 46200010000610
GPI class Bisacodyl EC
GCN Seq No 002947
GCN 08762
HICL code 001301
Ingredient (HICL) Bisacodyl
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name LAXATIVE EC 5 MG TABLET
FDB brand name Laxative
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 49483-003-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49483-0003-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerTIME CAP LABORATORIES, INC.
FDA applicationpart334 (OTC MONOGRAPH NOT FINAL)
Labeler code49483
First marketedApr 2014
Product typeHuman Otc Drug
Portfolio25 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name LAXATIVE EC 5 MG TABLET Ingredient Bisacodyl
📗 Our plain-language guide HelloPharmacist
  • It depends on which form you're using. Oral tablets (like Dulcolax Stimulant Laxative) usually take 6 to 12 hours, so many people take them at bedtime and get results in the mornin...
  • No — it's really important not to chew, crush, or break bisacodyl tablets. They have a special protective coating that helps them reach the right part of your gut without irritatin...
  • Can I chew or crush the tablet if I have trouble swallowing?
  • Milk and antacids can break down the protective coating on bisacodyl tablets too soon, before the medicine reaches where it needs to work. This can cause stomach irritation and mak...
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color orange
ShapeRound
ImprintTCL003
Size5 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.046 $46.40 / 1000 tablets
Medicaid paysCMS SDUD · 12 mo $0.2307 $230.70 / 1000 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Jul 2022 Dec 2025 Aug 2026 $0.054 $0.034
▲ Up 11% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 5 mg 00904-6407-61 Major 10 tablets $0.046 Availability likely
Bisacodyl 5 mg 00904-6748-17 Major 25 tablets $0.046 Availability likely
Womens Gentle Laxative 5 mg 46122-0429-63 Amerisource 25 tablets $0.046 Availability likely
Gentle Laxative 5 mg 46122-0529-63 Amerisource 25 tablets $0.046 Availability likely
Stimulant Laxative 5 mgthis 49483-0003-10 TIME 1000 tablets $0.046 Availability likely
Gentle Laxative 5 mg 70000-0221-01 Cardinal 10 tablets $0.046 Availability likely
Gentle Laxative 5 mg 70000-0538-01 CARDINAL 100 tablets $0.046 Availability likely
Laxative 5 mg 70677-1086-01 Strategic 10 tablets $0.046 Availability likely
Gentle Laxative 5 mg 83324-0033-30 Chain 15 tablets $0.046 Availability likely
Laxative 5 mg 83324-0061-30 Chain 25 tablets $0.046 Availability likely
Fleet 5 mg 00132-0401-25 C.B. 25 tablets FDA listed
Gentle Laxative 5 mg 00363-0327-03 Walgreen 10 tablets FDA listed
Laxative 5 mg 00363-6760-01 Walgreen 15 tablets FDA listed
up and up gentle laxative 5 mg 11673-0116-25 Target 25 tablets FDA listed
Womens Gentle Laxative 5 mg 11673-0151-52 TARGET 25 tablets FDA listed
Bisacodyl 5 mg 11673-0182-52 TARGET 25 tablets FDA listed
laxative for women 5 mg 11822-0676-05 Rite 15 tablets FDA listed
Laxative 5 mg 11822-0790-01 Rite 25 tablets FDA listed
Gentle Laxative 5 mg 21130-0410-20 BETTER 200 tablets FDA listed
Womens Gentle Laxative 5 mg 21130-0555-30 BETTER 30 tablets FDA listed
Gentle Overnight Laxative 5 mg 21130-0827-06 Better 200 tablets Discontinued
Laxative Gentle 5 mg 30142-0827-12 Kroger 25 tablets FDA listed
Gentle Laxative 5 mg 36800-0327-03 Topco 10 tablets FDA listed
Gentle Laxative 5 mg 37808-0327-15 H 25 tablets FDA listed
Womens Laxative 5 mg 37808-0676-11 H 15 tablets Discontinued
Gentle Laxative 5 mg 37808-0680-11 H 15 tablets FDA listed
Laxative 5 mg 37835-0241-01 Bi-Mart 100 tablets FDA listed
Gentle Laxative 5 mg 37835-0244-30 Bi-Mart 15 tablets FDA listed
Gentle Laxative 5 mg 41163-0607-52 United 18 tablets FDA listed
Dulcolax Simulant Laxative 5 mg 41167-0101-00 Chattem, 8 tablets FDA listed
Dulcolax Stimulant Laxative 5 mg 41167-0200-01 Chattem, 10 tablets FDA listed
Dulcolax Pink Stimulant Laxative 5 mg 41167-0290-05 Chattem, 25 tablets FDA listed
Dulcolax Stimulant Laxative 5 mg 41167-0400-01 Chattem, 10 tablets FDA listed
Bisacodyl 5 mg 41226-0003-52 KROGER 25 tablets FDA listed
Womens Laxative 5 mg 41226-0151-52 KROGER 25 tablets FDA listed
gentle laxative 5 mg 41250-0339-56 Meijer 25 tablets FDA listed
Womens gentle laxative 5 mg 41250-0676-11 Meijer 15 tablets FDA listed
Publix Stimulant Laxative 5 mg 41415-0116-25 PUBLIX 25 tablets FDA listed
Publix Women Laxative 5 mg 41415-0121-30 PUBLIX 30 tablets FDA listed
Gentle Laxative 5 mg 46122-0767-11 Amerisource 25 tablets FDA listed
Gentle Laxative 5 mg 49035-0327-12 Wal-Mart 100 tablets FDA listed
Gentle Laxative 5 mg 49035-0706-12 Wal-Mart 100 tablets FDA listed
Bisacodyl Laxative 5 mg 50804-0327-56 Geiss, 25 tablets FDA listed
Gentle Laxative 5 mg 50844-0327-15 L.N.K. 25 tablets FDA listed
Womens Gentle Laxative 5 mg 53943-0676-01 Discount 15 tablets FDA listed
Gentle Laxative 5 mg 53943-0677-01 Discount 15 tablets FDA listed
Bisacodyl 5 mg 55154-6897-00 Cardinal 1 tablet FDA listed
Laxative 5 mg 55319-0327-15 Family 25 tablets FDA listed
Gentle Laxative 5 mg 55319-0697-56 Family 25 tablets FDA listed
Laxomil 5 mg 55758-0504-01 Pharmadel 24 tablets FDA listed
Gentle Laxative 5 mg 55910-0327-62 DOLGENCORP, 15 tablets FDA listed
Laxative Gentle 5 mg 55910-0723-62 DOLGENCORP, 15 tablets FDA listed
Laxative 5 mg 55910-0792-56 DOLGENCORP, 25 tablets FDA listed
Extra Gentle Laxative 5 mg 55910-0954-52 DOLGENCORP 25 tablets FDA listed
laxative 5 mg 56062-0327-56 Publix 25 tablets FDA listed
Laxative 5 mg 56062-0976-01 Publix 15 tablets FDA listed
stimulant laxative enteric coated 5 mg 57896-0441-01 Geri-Care 100 tablets FDA listed
Gentle Laxative 5 mg 59779-0327-03 CVS 10 tablets FDA listed
C-Lax Laxative 5 mg 59779-0676-13 CVS 250 tablets FDA listed
Womens Gentle Laxative 5 mg 63868-0573-30 CHAIN 15 tablets FDA listed
Gentle Laxative Stimulant Laxative 5 mg 63868-0908-25 QUALITY 25 tablets FDA listed
Stimulant Laxative Enteric Coated 5 mg 66424-0002-01 SDA 100 tablets FDA listed
Laxative Gentle 5 mg 67091-0215-25 WinCo 25 tablets FDA listed
Laxative Women 5 mg 67091-0286-30 WinCo 15 tablets Discontinued
Laxative 5 mg 67091-0452-24 WinCo 15 tablets FDA listed
Bisacodyl 5 mg 68016-0688-10 Chain 100 tablets FDA listed
Bisacodyl Stimulant Laxative 5 mg 68163-0116-25 Raritan 25 tablets FDA listed
Womens Laxative 5 mg 68998-0398-85 Marc 25 tablets FDA listed
Laxative Enteric Coated 5 mg 68998-0404-92 Marc 25 tablets FDA listed
Bisacodyl 5mg 5 mg 69168-0398-92 Allegiant 25 tablets FDA listed
Laxative Enteric Coated 5 mg 69168-0404-03 Allegiant 250 tablets FDA listed
stimulant laxative 5 mg 69452-0541-83 BIONPHARMA 300 tablets FDA listed
Womens Gentle Laxative 5 mg 69842-0089-52 CVS 25 tablets FDA listed
Womens Laxative Enteric Coated 5 mg 70000-0570-01 CARDINAL 25 tablets FDA listed
GOOD REMEDIES GENTLE Laxative 5 mg 70692-0167-52 Strive 25 tablets FDA listed
RIGHT REMEDIES OVERNIGHT Laxative 5 mg 70692-0761-31 Strive 300 tablets FDA listed
stimulant laxative enteric coated 5 mg 71335-1531-00 Bryant 25 tablets FDA listed
Bisacodyl 5 mg 71335-2010-00 Bryant 25 tablets FDA listed
stimulant laxative enteric coated 5 mg 71610-0453-02 Aphena 2 tablets FDA listed
Bisacodyl 5 mg 71610-0700-02 Aphena 2 tablets FDA listed
Bisacodyl 5 mg 72090-0131-01 Pioneer 300 tablets FDA listed
Laxative 5 mg 76162-0676-01 TOPCO 15 tablets FDA listed
SIMPEX Bisacodyl laxative 5 mg 76457-0003-00 Simpex 100 tablets FDA listed
Gentle Laxative 5 mg 79903-0178-08 Wal-Mart 8 tablets FDA listed
Laxative 5 mg 80513-0409-20 Advanced 200 tablets FDA listed
Laxative 5 mg 83586-0116-01 HHH 100 tablets FDA listed
Bisacodyl 5 mg 84324-0132-01 NUVICARE 100 tablets FDA listed
stimulant laxative enteric coated 5 mg 85766-0148-00 Sportpharm 1000 tablets FDA listed
Laxative Enteric Coated 5 mg 85828-0404-92 Grocery 25 tablets FDA listed
Laxative 5 mg 79481-6760-01 Meijer 15 tablets FDA listed
Bisacodyl 5 mg 83586-0012-00 HHH 310000 tablets FDA listed
Stimulant Laxative Gentle 5 mg 51316-0327-03 CVS 10 tablets FDA listed
Gentle Laxative 5 mg 50804-0329-56 Geiss, 25 tablets FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Apr 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 49483-0003-10, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
14.4K
Units reimbursed last 4 qtrs
447K
Gross reimbursed last 4 qtrs
$103.1K
Avg / prescription
$7.15
Avg / unit
$0.2307
Latest quarter Q4 2025
3.3KRx
Medicaid pays / ea
$0.2307
gross reimbursed
vs
NADAC / ea
$0.0464
acquisition cost
=
Spread
+$0.1843
+397% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
56% FFS 44% MCO
Fee-for-service · 8,117 Rx Managed care · 6,300 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 4,104 units · 52.5 per 100k residents WA Idaho: no data reported ID Montana: 1,631 units · 144 per 100k residents MT North Dakota: no data reported ND Minnesota: 10,830 units · 189 per 100k residents MN Wisconsin: no data reported WI Michigan: 52,202 units · 520 per 100k residents MI New York: 58,325 units · 298 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 6,461 units · 153 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 13,676 units · 109 per 100k residents IL Indiana: 41,897 units · 611 per 100k residents IN Ohio: 28,725 units · 244 per 100k residents OH Pennsylvania: 42,552 units · 328 per 100k residents PA New Jersey: 14,068 units · 151 per 100k residents NJ Massachusetts: no data reported MA California: 127,307 units · 327 per 100k residents CA Utah: 786 units · 23.0 per 100k residents UT Colorado: no data reported CO Nebraska: 5,509 units · 279 per 100k residents NE Missouri: 23,066 units · 372 per 100k residents MO Kentucky: 14,326 units · 317 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: 1,498 units · 24.2 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
23.0611
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Indiana 611 /100k
2 Michigan 520 /100k
3 Missouri 372 /100k
4 Pennsylvania 328 /100k
5 California 327 /100k
6 Kentucky 317 /100k
7 New York 298 /100k
8 Nebraska 279 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 tablets49483-0003-01 58,523 Rx · $289,837
1000 tablets this page49483-0003-10 14,417 Rx · $103,111
100000 tablets49483-0003-00 No Medicaid data
25 tablets49483-0003-52 No Medicaid data
Drug total (last 4 qtrs): 72,940 Rx · 1,813,892 units · $392,948 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for stimulant laxative (this brand).

Top reported reactions

Constipation1,894
Nausea1,649
Pain1,570
Pyrexia1,238
Dyspnoea1,224
Vomiting1,190
Fatigue1,188

Reporter sex

18,128 reports

Serious outcomes

Hospitalization9,676
Death3,172
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1,806 707
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
49483-0003-00 100000 TABLET, DELAYED RELEASE in 1 CARTON (49483-003-00) 2018-12-07 Active
49483-0003-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (49483-003-01) $0.0464 / ea $4.64 2018-12-07 Active
49483-0003-10 You're viewing this 1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (49483-003-10) $0.0464 / ea $46.37 2018-12-07 Active
49483-0003-52 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK (49483-003-52) 2018-12-07 Active

You're viewing one of 4 pack sizes for this product.

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0464 NADAC).

This pack accounts for about 20% of this product's recent Medicaid fills; most go to the 100 tablets pack. See all packs ↓

Pack size FAQ

What quantity is in NDC 49483-0003-10?
NDC 49483-0003-10 is a 1,000-count package — 1000 tablet, delayed release in 1 bottle, plastic.
What is the difference between NDC 49483-0003-10 and NDC 49483-0003-52?
Both are STIMULANT LAXATIVE BISACODYL 5 mg Tablet, Delayed Release — the drug itself is identical. NDC 49483-0003-10 is the 1,000-count package, while NDC 49483-0003-52 is the 25 tablets package.
What NDC number is used to bill for this package of STIMULANT LAXATIVE BISACODYL 5 mg Tablet, Delayed Release?
Bill NDC 49483-0003-10 — the 11-digit billing format is 49483000310. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 18 words

Uses: relieves occasional constipation and irregularity this product generally produces a bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 38 words

adults and children 12 years and over: take 1 to 3 tablets in a single daily dose children 6 to under 12 years: take 1 tablet in a single daily dose children under 6 years: ask a doctor

⚠️ Warnings 70 words

Warning: Do not use if you cannot swallow without chewing. Ask a doctor before use if you have: stomach pain, nausea or vomiting; A sudden change in bowel habits that lasts more than two weeks. When using this product: Do not chew or crush tablet(s); Do not use within 1 hour after taking an antacid or milk; Do not use this product if you have stomach discomfort, faintness or cramps.

🧪 Active Ingredient 5 words

In each tablet: Bisacodyl 5mg

🧪 Inactive Ingredients 56 words

Acadia, Anhydrous Calcium Sulfate, Anhydrous Lactose, Carnauba Wax, Colloidal Silicon Dioxide, Corn Starch, D&C Yellow #10 Aluminum Lake, FD&C yellow #6 aluminum lake, Gelatin, Iron Oxide, Iron Oxide Black, Iron Oxide Yellow(Iron Oxide Ochre), Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol (PEG) 400, Polyvinyl Acetate Phthalates, Povidone, Shellac, Sodium Starch Glycolate, Stearic Acid, Sugar, Talc, Titanium Dioxide

🎯 Purpose 2 words

Stimulant Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.